ETV6-NTRK3: A chimeric protein tyrosine kinase with transformation activity in multiple cell lineages

Seminars in Cancer Biology

Volumn 15, Issue 3, 2005, Pages 215-223

  Lannon, Chris L ^a   Sorensen, Poul H B ^a  

^a UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Chimeric tyrosine kinase; ETV6 NTRK3; IRS 1; Tel; Translocation

Indexed keywords

ADAPTOR PROTEIN; CHIMERIC PROTEIN; INSULIN RECEPTOR SUBSTRATE 1; MITOGEN ACTIVATED PROTEIN KINASE; NEUROTROPHIN 3 RECEPTOR; ONCOPROTEIN; PHOSPHATIDYLINOSITOL 3 KINASE; PROTEIN KINASE B; PROTEIN TYROSINE KINASE; SOMATOMEDIN C RECEPTOR; TRANSCRIPTION FACTOR ETV6; UNCLASSIFIED DRUG;

ACUTE GRANULOCYTIC LEUKEMIA; BREAST CARCINOGENESIS; BREAST CARCINOMA; CARCINOGENESIS; CELL LINEAGE; CELL TRANSFORMATION; CHROMOSOME TRANSLOCATION; CHROMOSOME TRANSLOCATION 12; CHROMOSOME TRANSLOCATION 13; CONGENITAL FIBROSARCOMA; ENZYME ACTIVITY; GENE FUNCTION; GENE FUSION; HUMAN; MESOBLASTIC NEPHROMA; OLIGOMERIZATION; POLYMERIZATION; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN MOTIF; RECEPTOR GENE; REVIEW; SIGNAL TRANSDUCTION; SOFT TISSUE CANCER;

EID: 17044431346     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.semcancer.2005.01.003     Document Type: Review

References (89)

1. P. Blume-Jensen, and T. Hunter Oncogenic kinase signalling Nature 411 6835 2001 355 365
2. I.D. Clarke, and P.B. Dirks A human brain tumor-derived PDGFR-alpha deletion mutant is transforming Oncogene 22 5 2003 722 733
3. S. Meshinchi, D.L. Stirewalt, T.A. Alonzo, Q. Zhang, D.A. Sweetser, and W.G. Woods Activating mutations of RTK/Ras signal transduction pathway in pediatric acute myeloid leukemia Blood 102 4 2003 1474 1479
4. M. Ladanyi Aberrant ALK tyrosine kinase signaling. Different cellular lineages, common oncogenic mechanisms Am J Pathol 157 2 2000 341 345
5. L.C. Wang, W. Swat, Y. Fujiwara, L. Davidson, J. Visvader, and F. Kuo The TEL/ETV6 gene is required specifically for hematopoiesis in the bone marrow Genes Dev 12 15 1998 2392 2402
6. T.R. Golub, G.F. Barker, S.K. Bohlander, S.W. Hiebert, D.C. Ward, and P. Bray-Ward Fusion of the TEL gene on 12p13 to the AML1 gene on 21q22 in acute lymphoblastic leukaemia Proc Natl Acad Sci USA 92 1995 4917 4921
7. S.P. Romana, M. Mauchauffe, M. Le Coniat, I. Chumakov, D. Le Paslier, and R. Berger The t(12;21) of acute lymphoblastic leukemia results in a tel-AML1 gene fusion Blood 85 12 1995 3662 3670
8. T.R. Golub, G.F. Barker, M. Lovett, and D.G. Gilliland Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation Cell 77 2 1994 307 316
9. P. Papadopoulos, S.A. Ridge, C.A. Boucher, C. Stocking, and L.M. Wiedemann The novel activation of ABL by fusion to an ets-related gene, TEL Cancer Res 55 1 1995 34 38
10. T.R. Golub, A. Goga, G.F. Barker, D.E. Afar, J. McLaughlin, and S.K. Bohlander Oligomerization of the ABL tyrosine kinase by the Ets protein TEL in human leukemia Mol Cell Biol 16 8 1996 4107 4116
11. V. Lacronique, A. Boureux, V.D. Valle, H. Poirel, C.T. Quang, and M. Mauchauffe A TEL-JAK2 fusion protein with constitutive kinase activity in human leukemia Science 278 5341 1997 1309 1312
12. P. Peeters, S.D. Raynaud, J. Cools, I. Wlodarska, J. Grosgeorge, and P. Philip Fusion of TEL, the ETS-variant gene 6 (ETV6), to the receptor-associated kinase JAK2 as a result of t(9;12) in a lymphoid and t(9;15;12) in a myeloid leukemia Blood 90 7 1997 2535 2540
13. J. Schwaller, J. Frantsve, J. Aster, I.R. Williams, M.H. Tomasson, and T.S. Ross Transformation of hematopoietic cell lines to growth-factor independence and induction of a fatal myelo- and lymphoproliferative disease in mice by retrovirally transduced TEL/JAK2 fusion genes Embo J 17 18 1998 5321 5333
14. G. Cazzaniga, S. Tosi, A. Aloisi, G. Giudici, M. Daniotti, and P. Pioltelli The tyrosine kinase abl-related gene ARG is fused to ETV6 in an AML-M4Eo patient with a t(1;12)(q25;p13): molecular cloning of both reciprocal transcripts Blood 94 12 1999 4370 4373
15. Y. Iijima, T. Ito, T. Oikawa, M. Eguchi, M. Eguchi-Ishimae, and N. Kamada A new ETV6/TEL partner gene, ARG (ABL-related gene or ABL2), identified in an AML-M3 cell line with a t(1;12)(q25;p13) translocation Blood 95 6 2000 2126 2131
16. F. Yagasaki, D. Wakao, Y. Yokoyama, Y. Uchida, I. Murohashi, and H. Kayano Fusion of ETV6 to fibroblast growth factor receptor 3 in peripheral T-cell lymphoma with a t(4;12)(p16;p13) chromosomal translocation Cancer Res 61 23 2001 8371 8374
17. J.D. Rowley The role of chromosome translocations in leukemogenesis Semin Hematol 36 4 Suppl. 7 1999 59 72
18. S.R. Knezevich, D.E. McFadden, W. Tao, J.F. Lim, and P.H. Sorensen A novel ETV6-NTRK3 gene fusion in congenital fibrosarcoma Nat Genet 18 2 1998 184 187
19. D.R. Kaplan, and F.D. Miller Neurotrophin signal transduction in the nervous system Curr Opin Neurobiol 10 3 2000 381 391
20. D.H. Wai, S.R. Knezevich, T. Lucas, B. Jansen, R.J. Kay, and P.H. Sorensen The ETV6-NTRK3 gene fusion encodes a chimeric protein tyrosine kinase that transforms NIH3T3 cells Oncogene 19 7 2000 906 915
21. Q. Liu, J. Schwaller, J. Kutok, D. Cain, J.C. Aster, and I.R. Williams Signal transduction and transforming properties of the TEL-TRKC fusions associated with t(12;15)(p13;q25) in congenital fibrosarcoma and acute myelogenous leukaemia EMBO J 19 8 2000 1827 1838
22. C. Tognon, S.R. Knezevich, D. Huntsman, C.D. Roskelley, N. Melnyk, and J.A. Mathers Expression of the ETV6-NTRK3 gene fusion as a primary event in human secretory breast carcinoma Cancer Cell 2 5 2002 367 376
23. C. Fisher Fibromatosis and fibrosarcoma in infancy and childhood Eur J Cancer 32A 12 1996 2094 2100
24. F.M. Enzinger, and S.W. Weiss Soft tissue tumors 1995 St. Louis C.V. Mosby
25. J.M. Bourgeois, S.R. Knezevich, J.A. Mathers, and P.H.B. Sorensen Molecular detection of the ETV6-NTRK3 gene fusion differentiates congenital fibrosarcoma from other childhood spindle cell tumours Am J Surg Path 24 2000 937 946
26. T.J. Triche, and Sorensen PHB Molecular pathology of pediatric malignancies P.A. Pizzo D.G. Poplack Principles and practice of pediatric oncology 4th ed. 2002 Lippincott Williams & Wilkins Philadelphia 161 204
27. S.R. Knezevich, M.J. Garnett, T.J. Pysher, J.B. Beckwith, P.E. Grundy, and P.H. Sorensen ETV6-NTRK3 gene fusions and trisomy 11 establish a histogenetic link between mesoblastic nephroma and congenital fibrosarcoma Cancer Res 58 22 1998 5046 5048
28. B.P. Rubin, C.J. Chen, T.W. Morgan, S. Xiao, H.E. Grier, and H.P. Kozakewich Congenital mesoblastic nephroma t(12;15) is associated with ETV6-NTRK3 gene fusion: cytogenetic and molecular relationship to congenital (infantile) fibrosarcoma Am J Pathol 153 5 1998 1451 1458
29. P. Argani, M. Fritsch, S.S. Kadkol, A. Schuster, J.B. Beckwith, and E.J. Perlman Detection of the ETV6-NTRK3 chimeric RNA of infantile fibrosarcoma/cellular congenital mesoblastic nephroma in paraffin-embedded tissue: application to challenging pediatric renal stromal tumors Mod Pathol 13 1 2000 29 36
30. D.P. O'Malley, G.W. Mierau, J.B. Beckwith, and D.A. Weeks Ultrastructure of cellular congenital mesoblastic nephroma Ultrastruct Pathol 20 5 1996 417 427
31. P. Argani, and P.H.B. Sorensen Congenital mesoblastic nephroma J.N. Eble G. Sauter J.I. Epstein I.A. Sesterhenn Tumours of the urinary system and male genital organs 2004 IARC Press Lyon
32. R. Baserga The contradictions of the insulin-like growth factor 1 receptor Oncogene 19 49 2000 5574 5581
33. H.A. Oberman Secretory carcinoma of the breast in adults Am J Surg Pathol 4 5 1980 465 470
34. D.L. Page, T.J. Anderson, and G. Sakamoto Infiltrating carcinoma: major histologic types D.L. Page T.J. Anderson Diagnostic histopathology of the breast 1987 Churchill Livingstone Edinburgh
35. E. de Bree, J. Askoxylakis, E. Giannikaki, N. Chroniaris, E. Sanidas, and D.D. Tsiftsis Secretory carcinoma of the male breast Annu Surg Oncol 9 7 2002 663 667
36. H. Herz, B. Cooke, and D. Goldstein Metastatic secretory breast cancer. Non-responsiveness to chemotherapy: case report and review of the literature Annu Oncol 11 10 2000 1343 1347
37. F.A. Tavassoli, and H.J. Norris Secretory carcinoma of the breast Cancer 45 9 1980 2404 2413
38. P.P. Rosen, and M.L. Cranor Secretory carcinoma of the breast Arch Pathol Lab Med 115 2 1991 141 144
39. A. Maitra, F.A. Tavassoli, J. Albores-Saavedra, C. Behrens, I.I. Wistuba, and D. Bryant Molecular abnormalities associated with secretory carcinomas of the breast Hum Pathol 30 12 1999 1435 1440
40. M. Eguchi, M. Eguchi-Ishimae, A. Tojo, K. Morishita, K. Suzuki, and Y. Sato Fusion of ETV6 to neurotrophin-3 receptor TRKC in acute myeloid leukemia with t(12;15)(p13;q25) Blood 93 4 1999 1355 1363
41. A. Slupianek, G. Hoser, I. Majsterek, A. Bronisz, M. Malecki, and J. Blasiak Fusion tyrosine kinases induce drug resistance by stimulation of homology-dependent recombination repair, prolongation of G(2)/M phase, and protection from apoptosis Mol Cell Biol 22 12 2002 4189 4201
42. A.J. Alessandri, S.R. Knezevich, J.A. Mathers, K.R. Schultz, and P.H. Sorensen Absence of t(12;15) associated ETV6-NTRK3 fusion transcripts in pediatric acute leukemias Med Pediatr Oncol 37 4 2001 415 416
43. I. Bongarzone, M.A. Pierotti, N. Monzini, P. Mondellini, G. Manenti, and R. Donghi High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma Oncogene 4 12 1989 1457 1462
44. S. Pahlman, and J.C. Hoehner Neurotrophin receptors, tumor progression and tumor maturation Mol Med Today 2 10 1996 432 438
45. S.J. Miknyoczki, D. Lang, L. Huang, A.J. Klein-Szanto, C.A. Dionne, and B.A. Ruggeri Neurotrophins and Trk receptors in human pancreatic ductal adenocarcinoma: expression patterns and effects on in vitro invasive behavior Int J Cancer 81 3 1999 417 427
46. G.W. Reuther, Q.T. Lambert, M.A. Caligiuri, and C.J. Der Identification and characterization of an activating TrkA deletion mutation in acute myeloid leukemia Mol Cell Biol 20 23 2000 8655 8666
47. A.T. Weeraratna, J.T. Arnold, D.J. George, A. DeMarzo, and J.T. Isaacs Rational basis for Trk inhibition therapy for prostate cancer Prostate 45 2 2000 140 148
48. E.T. Walch, and D. Marchetti Role of neurotrophins and neurotrophins receptors in the in vitro invasion and heparanase production of human prostate cancer cells Clin Exp Metastasis 17 4 1999 307 314
49. D. Melck, L. De Petrocellis, P. Orlando, T. Bisogno, C. Laezza, and M. Bifulco Suppression of nerve growth factor Trk receptors and prolactin receptors by endocannabinoids leads to inhibition of human breast and prostate cancer cell proliferation Endocrinology 141 1 2000 118 126
50. M. Hisaoka, W.Q. Sheng, A. Tanaka, and H. Hashimoto Gene expression of TrkC (NTRK3) in human soft tissue tumours J Pathol 197 5 2002 661 667
51. A. Bardelli, D.W. Parsons, N. Silliman, J. Ptak, S. Szabo, and S. Saha Mutational analysis of the tyrosine kinome in colorectal cancers Science 300 5621 2003 949
52. J.R. McWhirter, D.L. Galasso, and J.Y. Wang A coiled-coil oligomerization domain of Bcr is essential for the transforming function of Bcr-Abl oncoproteins Mol Cell Biol 13 12 1993 7587 7595
53. M. Carroll, M.H. Tomasson, G.F. Barker, T.R. Golub, and D.G. Gilliland The TEL/platelet-derived growth factor beta receptor (PDGF beta R) fusion in chronic myelomonocytic leukemia is a transforming protein that self-associates and activates PDGF beta R kinase-dependent signaling pathways Proc Natl Acad Sci USA 93 25 1996 14845 14850
54. R.Y. Bai, P. Dieter, C. Peschel, S.W. Morris, and J. Duyster Nucleophosmin-anaplastic lymphoma kinase of large-cell anaplastic lymphoma is a constitutively active tyrosine kinase that utilizes phospholipase C-gamma to mediate its mitogenicity Mol Cell Biol 18 12 1998 6951 6961
55. C. Tognon, M. Garnett, E. Kenward, R. Kay, K. Morrison, and P.H. Sorensen The chimeric protein tyrosine kinase ETV6-NTRK3 requires both Ras-Erk1/2 and PI3-kinase-Akt signaling for fibroblast transformation Cancer Res 61 24 2001 8909 8916
56. H. Gille, and J. Downward Multiple Ras effector pathways contribute to G(1) cell cycle progression J Biol Chem 274 31 1999 22033 22040
57. I. Treinies, H.F. Paterson, S. Hooper, R. Wilson, and C.J. Marshall Activated MEK stimulates expression of AP-1 components independently of phosphatidylinositol 3-kinase (PI3-kinase) but requires a PI3-kinase signal To stimulate DNA synthesis Mol Cell Biol 19 1 1999 321 329
58. M.P. Scheid, and J.R. Woodgett Protein kinases: six degrees of separation? Curr Biol 10 5 2000 191 194
59. R. Baserga The insulin-like growth factor I receptor: a key to tumor growth? Cancer Res 55 2 1995 249 252
60. R. Baserga, F. Peruzzi, and K. Reiss The IGF-1 receptor in cancer biology Int J Cancer 107 6 2003 873 877
61. R. Baserga The IGF-I receptor in cancer research Exp Cell Res 253 1 1999 1 6
62. J.A. Toretsky, and L.J. Helman Involvement of IGF-II in human cancer J Endocrinol 149 3 1996 367 372
63. K.B. Morrison, C.E. Tognon, M.J. Garnett, C. Deal, and P.H. Sorensen ETV6-NTRK3 transformation requires insulin-like growth factor 1 receptor signaling and is associated with constitutive IRS-1 tyrosine phosphorylation Oncogene 21 37 2002 5684 5695
64. J.A. Toretsky, T. Kalebic, V. Blakesley, D. LeRoith, and L.J. Helman The insulin-like growth factor-I receptor is required for EWS/FLI-1 transformation of fibroblasts J Biol Chem 272 49 1997 30822 30827
65. W. Wang, P. Kumar, J. Epstein, L. Helman, J.V. Moore, and S. Kumar Insulin-like growth factor II and PAX3-FKHR cooperate in the oncogenesis of rhabdomyosarcoma Cancer Res 58 19 1998 4426 4433
66. C.L. Lannon, M.J. Martin, C.E. Tognon, W. Jin, S.J. Kim, and P.H. Sorensen A highly conserved NTRK3 C-terminal sequence in the ETV6-NTRK3 oncoprotein binds the phosphotyrosine binding domain of insulin receptor substrate-1: an essential interaction for transformation J Biol Chem 279 8 2004 6225 6234
67. C. Miranda, A. Greco, C. Miele, M.A. Pierotti, and E. Van Obberghen IRS-1 and IRS-2 are recruited by TrkA receptor and oncogenic TRK-T1 J Cell Physiol 186 1 2001 35 46
68. F. Traina, J.B. Carvalheira, M.J. Saad, F.F. Costa, and S.T. Saad BCR-ABL binds to IRS-1 and IRS-1 phosphorylation is inhibited by imatinib in K562 cells FEBS Lett 535 1-3 2003 17 22
69. J. Fujimoto, M. Shiota, T. Iwahara, N. Seki, H. Satoh, and S. Mori Characterization of the transforming activity of p80, a hyperphosphorylated protein in a Ki-1 lymphoma cell line with chromosomal translocation t(2;5) Proc Natl Acad Sci USA 93 9 1996 4181 4186
70. P. Bonvini, T. Gastaldi, B. Falini, and A. Rosolen Nucleophosmin- anaplastic lymphoma kinase (NPM-ALK), a novel Hsp90-client tyrosine kinase: down-regulation of NPM-ALK expression and tyrosine phosphorylation in ALK(+) CD30(+) lymphoma cells by the Hsp90 antagonist 17-allylamino 17-demethoxygeldanamycin Cancer Res 62 5 2002 1559 1566
71. C.E. Tognon, C.D. Mackereth, A.M. Somasiri, L.P. McIntosh, and P.H. Sorensen Mutations in the SAM domain of the ETV6-NTRK3 chimeric tyrosine kinase block polymerization and transformation activity Mol Cell Biol 24 11 2004 4636 4650
72. C.A. Kim, M.L. Phillips, W. Kim, M. Gingery, H.H. Tran, and M.A. Robinson Polymerization of the SAM domain of TEL in leukemogenesis and transcriptional repression EMBO J 20 15 2001 4173 4182
73. H.H. Tran, C.A. Kim, S. Faham, M.C. Siddall, and J.U. Bowie Native interface of the SAM domain polymer of TEL BMC Struct Biol 2 1 2002 5
74. R. Schreck, P. Rieber, and P.A. Baeuerle Reactive oxygen intermediates as apparently widely used messengers in the activation of the NF-kappa B transcription factor and HIV-1 EMBO J 10 8 1991 2247 2258
75. L. Flohe, R. Brigelius-Flohe, C. Saliou, M.G. Traber, and L. Packer Redox regulation of NF-kappa B activation Free Radic Biol Med 22 6 1997 1115 1126
76. M. Hayakawa, H. Miyashita, I. Sakamoto, M. Kitagawa, H. Tanaka, and H. Yasuda Evidence that reactive oxygen species do not mediate NF-kappaB activation EMBO J 22 13 2003 3356 3366
77. S.C. Santos, R. Monni, I. Bouchaert, O. Bernard, S. Gisselbrecht, and F. Gouilleux Involvement of the NF-kappaB pathway in the transforming properties of the TEL-Jak2 leukemogenic fusion protein FEBS Lett 497 2-3 2001 148 152
78. L. Lamant, N. Dastugue, K. Pulford, G. Delsol, and B. Mariame A new fusion gene TPM3-ALK in anaplastic large cell lymphoma created by a (1;2)(q25;p23) translocation Blood 93 9 1999 3088 3095
79. B. Lawrence, A. Perez-Atayde, M.K. Hibbard, B.P. Rubin, P. Dal Cin, and J.L. Pinkus TPM3-ALK and TPM4-ALK oncogenes in inflammatory myofibroblastic tumors [see comments] Am J Pathol 157 2 2000 377 384
80. C. Touriol, C. Greenland, L. Lamant, K. Pulford, F. Bernard, and T. Rousset Further demonstration of the diversity of chromosomal changes involving 2p23 in ALK-positive lymphoma: 2 cases expressing ALK kinase fused to CLTCL (clathrin chain polypeptide-like) Blood 95 10 2000 3204 3207
81. J.A. Bridge, M. Kanamori, Z. Ma, D. Pickering, D.A. Hill, and W. Lydiatt Fusion of the ALK gene to the clathrin heavy chain gene, CLTC, in inflammatory myofibroblastic tumor Am J Pathol 159 2 2001 411 415
82. D.D.K. Prasad, M. Ouchida, L. Lee, V.N. Rao, and E.S.P. Reddy TLS/FUS fusion domain of TLS/FUS-erg chimeric protein resulting from the t(16;21) chromosomal translocation in human myeloid leukemia functions as a transcriptional activation domain Oncogene 9 1994 3717 3729
83. D.C. Shing, D.J. McMullan, P. Roberts, K. Smith, S.F. Chin, and J. Nicholson FUS/ERG gene fusions in Ewing's tumors Cancer Res 63 15 2003 4568 4576
84. M. Ladanyi, M.Y. Lui, C.R. Antonescu, A. Krause-Boehm, A. Meindl, and P. Argani The der(17)t(X;17)(p11;q25) of human alveolar soft part sarcoma fuses the TFE3 transcription factor gene to ASPL, a novel gene at 17q25 Oncogene 20 1 2001 48 57
85. P. Argani, C.R. Antonescu, P.B. Illei, M.Y. Lui, C.F. Timmons, and R. Newbury Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma: a distinctive tumor entity previously included among renal cell carcinomas of children and adolescents Am J Pathol 159 1 2001 179 192
86. F.G. Barr Translocations, cancer and the puzzle of specificity Nat Genet 19 2 1998 121 124
87. P.H. Sorensen, and T.J. Triche Gene fusions encoding chimaeric transcription factors in solid tumours Semin Cancer Biol 7 1 1996 3 14
88. M.A. Teitell, A.D. Thompson, P.H. Sorensen, H. Shimada, T.J. Triche, and C.T. Denny EWS/ETS fusion genes induce epithelial and neuroectodermal differentiation in NIH 3T3 fibroblasts Lab Invest 79 12 1999 1535 1543
89. J. Khan, M.L. Bittner, L.H. Saal, U. Teichmann, D.O. Azorsa, and G.C. Gooden cDNA microarrays detect activation of a myogenic transcription program by the PAX3-FKHR fusion oncogene Proc Natl Acad Sci USA 96 23 1999 13264 13269